Chembio Diagnostics, Inc.
CEMIDelisted Apr 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001092662
Chembio Diagnostics, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on May 2, 2023; 30 institutions reported holding it in 13F filings for Q1 2023, worth $1.36M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Chembio Diagnostics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 38 | 38 | 0 |
| Shares | 3.19M | 2.91M | −276.5K (−8.7%) |
| Value | $1.15M | $638.6K | −$511.4K (−44.5%) |
New holders (7)
Institutions that held Chembio Diagnostics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 80,619 | $18.0K | 0.00% |
| Susquehanna International Group, LLP | 56,869 | $12.5K | 0.00% |
| Jane Street Group, LLC | 21,688 | $4.76K | 0.00% |
| Freedom Wealth Alliance, LLC | 9,831 | $2.16K | 0.00% |
| Cornerstone Planning Group LLC | 1,000 | $341 | 0.00% |
| Harbour Investments, Inc. | 250 | $55 | 0.00% |
| Bank of America Corp | 86 | $18 | 0.00% |
Sold out (7)
Institutions that held Chembio Diagnostics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Millennium Management LLC | 191,303 | $69.0K |
| Royce & Associates LP | 135,800 | $49.0K |
| HRT Financial LP | 33,463 | $12.0K |
| Susquehanna Fundamental Investments, LLC | 29,000 | $10.0K |
| StoneX Group Inc. | 13,269 | $4.79K |
| Phocas Financial Corp. | 10,000 | $4.00K |
| Federated Hermes, Inc. | 1,106 | $1.00K |